NO20006138L - Substituted indolinones, preparation and use thereof as medicaments - Google Patents

Substituted indolinones, preparation and use thereof as medicaments

Info

Publication number
NO20006138L
NO20006138L NO20006138A NO20006138A NO20006138L NO 20006138 L NO20006138 L NO 20006138L NO 20006138 A NO20006138 A NO 20006138A NO 20006138 A NO20006138 A NO 20006138A NO 20006138 L NO20006138 L NO 20006138L
Authority
NO
Norway
Prior art keywords
medicaments
preparation
substituted indolinones
indolinones
substituted
Prior art date
Application number
NO20006138A
Other languages
Norwegian (no)
Other versions
NO20006138D0 (en
Inventor
Armin Heckel
Rainer Walter
Wolfgang Grell
Jacobus C A Van Meel
Norbert Redemann
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20006138D0 publication Critical patent/NO20006138D0/en
Publication of NO20006138L publication Critical patent/NO20006138L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006138A 1998-06-04 2000-12-01 Substituted indolinones, preparation and use thereof as medicaments NO20006138L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19824922A DE19824922A1 (en) 1998-06-04 1998-06-04 Novel substituted indolinones, their preparation and their use as pharmaceuticals
PCT/EP1999/003692 WO1999062882A1 (en) 1998-06-04 1999-05-28 Substituted indolinones, the production thereof and their use as medicaments

Publications (2)

Publication Number Publication Date
NO20006138D0 NO20006138D0 (en) 2000-12-01
NO20006138L true NO20006138L (en) 2001-02-01

Family

ID=7869856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006138A NO20006138L (en) 1998-06-04 2000-12-01 Substituted indolinones, preparation and use thereof as medicaments

Country Status (23)

Country Link
EP (1) EP1100779A1 (en)
JP (1) JP2002516906A (en)
KR (1) KR20010043973A (en)
CN (1) CN1303374A (en)
AU (1) AU764782B2 (en)
BG (1) BG104938A (en)
BR (1) BR9910898A (en)
CA (1) CA2328291A1 (en)
CO (1) CO5050294A1 (en)
DE (1) DE19824922A1 (en)
EA (1) EA003514B1 (en)
EE (1) EE200000723A (en)
HR (1) HRP20000831A2 (en)
HU (1) HUP0102210A3 (en)
ID (1) ID27035A (en)
IL (1) IL138702A0 (en)
NO (1) NO20006138L (en)
PL (1) PL344467A1 (en)
SK (1) SK18222000A3 (en)
TR (1) TR200003515T2 (en)
WO (1) WO1999062882A1 (en)
YU (1) YU73900A (en)
ZA (1) ZA200005435B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816624A1 (en) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
US6762180B1 (en) 1999-10-13 2004-07-13 Boehringer Ingelheim Pharma Kg Substituted indolines which inhibit receptor tyrosine kinases
UA75054C2 (en) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Substituted in position 6 indolinones, producing and use thereof as medicament
EP1339680A1 (en) * 2000-09-01 2003-09-03 Glaxo Group Limited Substituted oxindole derivatives as tyrosine kinase inhibitors
EP1317446A1 (en) * 2000-09-01 2003-06-11 Glaxo Group Limited Oxindole derivatives
DE10117204A1 (en) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma Indolinones substituted in the 6-position, their preparation and their use as medicaments
DE60216281T2 (en) 2001-06-29 2007-07-05 Ab Science THE USE OF TYROSINE KINASE INHIBITOR FOR THE TREATMENT OF ALLERGIC DISEASES
CA2452368A1 (en) 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
EP1401416B1 (en) * 2001-06-29 2006-10-25 AB Science Use of c-kit inhibitors for treating inflammatory bowel diseases (ibd)
CA2452169A1 (en) 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory diseases
DE60227709D1 (en) * 2001-06-29 2008-08-28 Ab Science THE USE OF C-CRITERIA FOR THE TREATMENT OF AUTOIMMUNE DISEASES
WO2003027102A1 (en) 2001-09-27 2003-04-03 Allergan, Inc. 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
JP4879492B2 (en) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド Kinase inhibitors for the treatment of diseases
DE102004012070A1 (en) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New cycloalkyl-containing 5-acylindolinones, their preparation and their use as medicaments
PE20060777A1 (en) * 2004-12-24 2006-10-06 Boehringer Ingelheim Int INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
CA2670285A1 (en) * 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
CN101735071A (en) * 2009-12-04 2010-06-16 大连凯飞精细化工有限公司 Method for producing 4-N,N-dimethylamino methylaniline
CN103102352B (en) * 2011-11-15 2015-08-12 山东亨利医药科技有限责任公司 Tyrosine kinase inhibitor indolinone derivative
CN103130775B (en) * 2011-11-22 2015-09-30 山东亨利医药科技有限责任公司 As the dihydroindole ketone derivate of tyrosine kinase inhibitor
GB201208775D0 (en) 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds
CN103848814B (en) * 2012-12-06 2016-08-17 山东亨利医药科技有限责任公司 The full ketone derivatives of substituted indole as tyrosine kinase inhibitor
EP3966207B1 (en) 2019-05-10 2023-11-01 Deciphera Pharmaceuticals, LLC Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
WO2024050297A1 (en) * 2022-09-02 2024-03-07 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE838623A (en) * 1976-02-16 1976-06-16 3-HYDROXYMETHYLENE-2-INDOLINONE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
US4145422A (en) * 1977-09-06 1979-03-20 Abbott Laboratories Aminomethylene oxindoles
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
EP1247803A3 (en) * 1996-08-23 2002-10-16 Sugen, Inc. Indolinone compounds suitable for modulation of protein kinases
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
KR20010043973A (en) 2001-05-25
AU4370799A (en) 1999-12-20
JP2002516906A (en) 2002-06-11
SK18222000A3 (en) 2001-08-06
AU764782B2 (en) 2003-08-28
HUP0102210A3 (en) 2002-12-28
EE200000723A (en) 2002-04-15
EP1100779A1 (en) 2001-05-23
CA2328291A1 (en) 1999-12-09
ZA200005435B (en) 2002-01-07
PL344467A1 (en) 2001-11-05
EA200100001A1 (en) 2001-08-27
DE19824922A1 (en) 1999-12-09
BG104938A (en) 2001-06-29
ID27035A (en) 2001-02-22
EA003514B1 (en) 2003-06-26
YU73900A (en) 2003-04-30
HUP0102210A2 (en) 2001-11-28
CO5050294A1 (en) 2001-06-27
WO1999062882A1 (en) 1999-12-09
HRP20000831A2 (en) 2001-12-31
NO20006138D0 (en) 2000-12-01
IL138702A0 (en) 2001-10-31
BR9910898A (en) 2001-02-13
CN1303374A (en) 2001-07-11
TR200003515T2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
NO20006138L (en) Substituted indolinones, preparation and use thereof as medicaments
DK1095025T3 (en) Benzimidazoles, their preparation and their use as drugs
DK1119557T3 (en) Indeno-, Naphtho- and Benzocyclohepta-dihydrothiazole derivatives, their preparation and their use as anorectic drugs
NO20011216L (en) Acetidine derivatives, their preparation and medicaments containing the compounds
NO20021719D0 (en) 6-position substituted indolines, preparation and use thereof as a drug
NO20005146D0 (en) Thienylazolylalkoxyethanamines, their preparation and their use as drugs
NO20012567D0 (en) Azepinoindole derivatives, preparation and use thereof
NO993003D0 (en) Sulfonamide derivatives, processes for their preparation and their use as medicaments
DK1083171T3 (en) Pyrazoline derivatives, their preparation and use as drugs
NO20015156L (en) 5-pyridyl-1,3-azole compounds, their preparation and use
NO991815D0 (en) Oxadiazoles, processes for their preparation and their use as drugs
NO20014603L (en) Tienopyrimidine Compounds, Their Preparation and Use
IS2076B (en) Acyl-piperazinil-pyrimidine derivatives, their preparation and use as pharmaceuticals
DK1073672T3 (en) Antipicornaviral compounds, their preparation and use
IS6420A (en) Presents Phenyl-piperazine derivatives, their preparation and use
NO20020156L (en) Titanium derived compounds, their preparation and their use
NO20004904D0 (en) C11 oxymyl and hydroxylaminoprostaglandins useful as medicaments
NO20006479D0 (en) Tienopyridine compounds, their preparation and use
NO20000066D0 (en) 6-Pyrrolidin-2-ylpyrindine Derivatives, their Preparation and their Pharmaceutical Use
NO996156L (en) Substituted cycloheptans, their preparation and use
DK1235809T3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as drugs
DK1072266T3 (en) Thienylazolylalkoxyethanamines, their preparation and their use as drugs
DK1127052T3 (en) Substituted 2-phenylbenzimidazoles, preparation and use thereof
EE200200229A (en) Diarylenines, composition and pharmaceutical composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application